This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its unique structure, featuring a dihydrobenzofuran core with fluorine substitutions, makes it valuable for developing drugs targeting central nervous system disorders, such as depression, anxiety, and neurodegenerative diseases. Additionally, it is employed in the creation of selective serotonin reuptake inhibitors (SSRIs) and other psychotropic medications, where its stereochemistry and functional groups play a critical role in enhancing drug efficacy and specificity. Researchers also explore its potential in designing novel therapeutic agents due to its ability to interact with biological targets with high affinity.